Literature DB >> 12692233

Inhibition of human immunodeficiency virus type 1 Env-mediated fusion by DC-SIGN.

Cinzia Nobile1, Arnaud Moris, Françoise Porrot, Nathalie Sol-Foulon, Olivier Schwartz.   

Abstract

DC-SIGN, a lectin expressed on dendritic cell and macrophage subsets, binds to human immunodeficiency virus Env glycoproteins, allowing capture of viral particles. Captured virions either infect target cells or are efficiently transmitted to lymphocytes. Cellular mechanisms underlying the effects of DC-SIGN remain poorly understood. Here we have analyzed the effects of DC-SIGN on viral entry and on syncytium formation induced by Env glycoproteins. The lectin enhanced susceptibility to viral infection and dramatically increased virion internalization. Captured virions accumulated in the vesicular pathway, and their access to the cytosol was altered. Strikingly, the presence of DC-SIGN on target cells inhibited their ability to form syncytia with Env-expressing cells. However, increasing CD4 surface levels on target cells alleviated this inhibitory effect of DC-SIGN. Moreover, the potency of the viral fusion inhibitor T-20 was not affected in DC-SIGN-expressing cells. Altogether, our results indicate that DC-SIGN exerts subtle and complex effects during early steps of HIV type 1 replication. DC-SIGN facilitates capture and accumulation of viral particles in a vesicular compartment and inhibits viral fusion. Competition between CD4 and DC-SIGN for Env binding likely affects virus access to the cytosol and syncytium formation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12692233      PMCID: PMC153976          DOI: 10.1128/jvi.77.9.5313-5323.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses.

Authors:  T B Geijtenbeek; R Torensma; S J van Vliet; G C van Duijnhoven; G J Adema; Y van Kooyk; C G Figdor
Journal:  Cell       Date:  2000-03-03       Impact factor: 41.582

2.  DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells.

Authors:  T B Geijtenbeek; D S Kwon; R Torensma; S J van Vliet; G C van Duijnhoven; J Middel; I L Cornelissen; H S Nottet; V N KewalRamani; D R Littman; C G Figdor; Y van Kooyk
Journal:  Cell       Date:  2000-03-03       Impact factor: 41.582

3.  Cell biology of virus entry.

Authors:  D S Dimitrov
Journal:  Cell       Date:  2000-06-23       Impact factor: 41.582

Review 4.  The role of DC-SIGN and DC-SIGNR in HIV and SIV attachment, infection, and transmission.

Authors:  F Baribaud; S Pöhlmann; R W Doms
Journal:  Virology       Date:  2001-07-20       Impact factor: 3.616

Review 5.  New targets for inhibitors of HIV-1 replication.

Authors:  J P Moore; M Stevenson
Journal:  Nat Rev Mol Cell Biol       Date:  2000-10       Impact factor: 94.444

6.  DC-SIGN-ICAM-2 interaction mediates dendritic cell trafficking.

Authors:  T B Geijtenbeek; D J Krooshoop; D A Bleijs; S J van Vliet; G C van Duijnhoven; V Grabovsky; R Alon; C G Figdor; Y van Kooyk
Journal:  Nat Immunol       Date:  2000-10       Impact factor: 25.606

7.  Nef is required for efficient HIV-1 replication in cocultures of dendritic cells and lymphocytes.

Authors:  C Petit; F Buseyne; C Boccaccio; J P Abastado; J M Heard; O Schwartz
Journal:  Virology       Date:  2001-07-20       Impact factor: 3.616

8.  Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry.

Authors:  J M Kilby; S Hopkins; T M Venetta; B DiMassimo; G A Cloud; J Y Lee; L Alldredge; E Hunter; D Lambert; D Bolognesi; T Matthews; M R Johnson; M A Nowak; G M Shaw; M S Saag
Journal:  Nat Med       Date:  1998-11       Impact factor: 53.440

9.  Virus replication begins in dendritic cells during the transmission of HIV-1 from mature dendritic cells to T cells.

Authors:  A Granelli-Piperno; V Finkel; E Delgado; R M Steinman
Journal:  Curr Biol       Date:  1999-01-14       Impact factor: 10.834

10.  DC-SIGN interactions with human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus.

Authors:  S Pöhlmann; F Baribaud; B Lee; G J Leslie; M D Sanchez; K Hiebenthal-Millow; J Münch; F Kirchhoff; R W Doms
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

View more
  15 in total

1.  DC-SIGN facilitates fusion of dendritic cells with human T-cell leukemia virus type 1-infected cells.

Authors:  Pierre-Emmanuel Ceccaldi; Frédéric Delebecque; Marie-Christine Prevost; Arnaud Moris; Jean-Pierre Abastado; Antoine Gessain; Olivier Schwartz; Simona Ozden
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

2.  A new C-type lectin similar to the human immunoreceptor DC-SIGN mediates symbiont acquisition by a marine nematode.

Authors:  Silvia Bulgheresi; Irma Schabussova; Tie Chen; Nicholas P Mullin; Rick M Maizels; Jörg A Ott
Journal:  Appl Environ Microbiol       Date:  2006-04       Impact factor: 4.792

3.  The core lipopolysaccharide of Escherichia coli is a ligand for the dendritic-cell-specific intercellular adhesion molecule nonintegrin CD209 receptor.

Authors:  John Klena; Pei Zhang; Olivier Schwartz; Sheila Hull; Tie Chen
Journal:  J Bacteriol       Date:  2005-03       Impact factor: 3.490

4.  Human immunodeficiency virus type 1 employs the cellular dynein light chain 1 protein for reverse transcription through interaction with its integrase protein.

Authors:  Kallesh Danappa Jayappa; Zhujun Ao; Xiaoxia Wang; Andrew J Mouland; Sudhanshu Shekhar; Xi Yang; Xiaojian Yao
Journal:  J Virol       Date:  2015-01-07       Impact factor: 5.103

5.  Neuropilin-1 is involved in human T-cell lymphotropic virus type 1 entry.

Authors:  David Ghez; Yves Lepelletier; Sophie Lambert; Jean-Marie Fourneau; Vincent Blot; Sébastien Janvier; Bertrand Arnulf; Peter M van Endert; Nikolaus Heveker; Claudine Pique; Olivier Hermine
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

Review 6.  Dendritic-cell interactions with HIV: infection and viral dissemination.

Authors:  Li Wu; Vineet N KewalRamani
Journal:  Nat Rev Immunol       Date:  2006-11       Impact factor: 53.106

7.  HIV Fusion in Dendritic Cells Occurs Mainly at the Surface and Is Limited by Low CD4 Levels.

Authors:  Lise Chauveau; Daniel Aaron Donahue; Blandine Monel; Francoise Porrot; Timothée Bruel; Lea Richard; Nicoletta Casartelli; Olivier Schwartz
Journal:  J Virol       Date:  2017-10-13       Impact factor: 5.103

8.  Covert human immunodeficiency virus replication in dendritic cells and in DC-SIGN-expressing cells promotes long-term transmission to lymphocytes.

Authors:  Cinzia Nobile; Caroline Petit; Arnaud Moris; Katharina Skrabal; Jean-Pierre Abastado; Fabrizio Mammano; Olivier Schwartz
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

9.  Characterization of human immunodeficiency virus type 1 replication in immature and mature dendritic cells reveals dissociable cis- and trans-infection.

Authors:  Chunsheng Dong; Alicia M Janas; Jian-Hua Wang; Wendy J Olson; Li Wu
Journal:  J Virol       Date:  2007-08-08       Impact factor: 5.103

10.  DC-SIGN from African green monkeys is expressed in lymph nodes and mediates infection in trans of simian immunodeficiency virus SIVagm.

Authors:  Mickaël J-Y Ploquin; Ousmane M Diop; Nathalie Sol-Foulon; Lorenzo Mortara; Abdourahmane Faye; Marcelo A Soares; Eric Nerrienet; Roger Le Grand; Yvette Van Kooyk; Ali Amara; Olivier Schwartz; Françoise Barré-Sinoussi; Michaela C Müller-Trutwin
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.